Summary

Udvikling af en Spyt Antibody Multiplex Immunoassay at måle menneskelig eksponering for miljømæssige patogener

Published: September 12, 2016
doi:

Summary

In the current climate of scarce resources, new technologies are emerging that allow researchers to conduct studies cheaper, faster and with more precision. Here we describe the development of a bead-based salivary antibody multiplex immunoassay to measure human exposure to multiple environmental pathogens simultaneously.

Abstract

Ætiologien og virkningerne af menneskers eksponering for miljømæssige patogener er af stor bekymring i hele verden og dermed vil evnen til at vurdere eksponering og infektioner ved hjælp omkostningseffektive, high-throughput tilgange være uundværlig. Dette håndskrift beskriver udviklingen og analyse af en perle-baserede multiplex immunoassay stand til at måle tilstedeværelsen af ​​antistoffer i humant spyt til flere patogener samtidigt. Spyt er særligt attraktivt i denne ansøgning, fordi det er noninvasiv, billigere og lettere at samle end serum. Antigener fra miljømæssige patogener blev koblet til carboxylerede mikrosfærer (perler) og anvendt til at måle antistoffer i meget små volumener af humane spytprøver bruger bead-baseret, opløsning-fase-assay. Perler blev koblet med antigener fra Campylobacter jejuni, Helicobacter pylori, Toxoplasma gondii, norovira (G I.1 og G II.4) og hepatitis A-virus. At sikre, at antigenerne tilstrækkeligt koblet for atperlerne, kobling blev bekræftet ved anvendelse artsspecifikke, animalsk afledte primære fangantistoffer, efterfulgt af inkubation med biotinylerede anti-species sekundære afsløring antistoffer og streptavidin-R-phycoerythrin reporter (SAPE). Som en kontrol for at måle ikke-specifik binding, blev en kanttråd sæt behandlet identisk til de andre undtagen det ikke blev koblet til nogen antigen. De antigen-koblet og kontrol Perlerne blev derefter inkuberet med prospektivt-indsamlede humane spytprøver, målt på et højt gennemløb analysator baseret på principperne om flowcytometri, og tilstedeværelsen af ​​antistoffer mod hvert antigen blev målt i gennemsnitlig fluorescensintensitet enheder (MFI) . Denne multiplex immunoassay har en række fordele, herunder flere data med mindre prøve; reducerede omkostninger og arbejdskraft; og evnen til at tilpasse assayet til mange mål af interesse. Resultaterne viser, at spyt multiplex immunoassay kan være i stand til at identificere tidligere eksponeringer og infektioner, som kan være especially nyttigt i overvågning undersøgelser med store befolkningsgrupper.

Introduction

Firs-otte procent af diarré-sygdom på verdensplan er forbundet med menneskers eksponering for forurenet vand, farlige fødevarer og dårlig sanitet / hygiejne, der forårsager ca. 1,5 millioner dødsfald, hvoraf de fleste er børn 1. Dette er en væsentlig årsag til bekymring for den offentlige sundhed embedsmænd og politikere. I et forsøg på at undersøge eksponeringer og sygdomme forbundet med vandbaseret og andre miljømæssige patogener, udviklede vi en multiplex immunoassay til måling af antistoffer i humane prøver 2-4. Denne metode kan anvendes på epidemiologiske undersøgelser for at bestemme menneskers udsættelse for disse patogener og for bedre at definere immunoprevalence og hændelser infektioner.

Spyt besidder betydelig lovende som et alternativ til serum til human biomarkør forskning. Blandt fordelene ved at anvende spyt er de ikke-invasivitet og let prøveindsamling, lave omkostninger, og prøver kan let indsamles fra børn 5-7 </ Sup>. Serum- og spytprøver er blevet omfattende undersøgt for antistoffer mod H. pylori 2,3,8, Plasmodium falciparum 9, Entamoeba histolytica 10, Cryptosporidium parvum 3,11, Streptococcus pneumonia 12, hepatitisvira A og C 13-14, norovira 2-4,15, T. gondii 2-4, dengue virus 16, humant immundefektvirus (HIV) 17, og Escherichia coli O157: H7 18.

En multiplex immunoassay tillader analyse af flere analytter samtidigt i en enkelt prøve volumen og inden for en enkelt cyklus eller løbe. Multipleksede antigener fra C. jejuni, T. gondii, H. pylori, blev hepatitis A virus og to norovira anvendes til måling humant spyt IgG 2-4 og IgA 3,4 og plasma IgG 2,3 antistofreaktioner til disse patogener under anvendelse af enperle-baserede multiplexing immunoassay. Når det bruges sammen med epidemiologiske undersøgelser af eksponering for mikrober i vand, jord og fødevarer, kan type assay er beskrevet i denne undersøgelse give værdifuld information til at øge forståelsen af ​​infektioner forårsaget af miljømæssige patogener. Desuden kan spyt antistof data fra sådanne undersøgelser anvendes til at forbedre risikovurderingsmodeller 19-22.

Protocol

Godkendelse blev opnået fra Institutional Review Board (IRB # 08-1844, University of North Carolina, Chapel Hill, NC, USA) til indsamling af stimulerede creviculære spytprøver fra beachgoers på Boquerón Beach, Puerto Rico, som en del af USA Environmental Protection Agency (USEPA) National epidemiologiske og miljøvurdering af Fritids (neear) Vand Study 23 for at vurdere svømning forbundet eksponeringer og sygdomme. Undersøgelse emner forudsat informeret samtykke og blev instrueret om brugen af ​​sp…

Representative Results

En unik perle sæt blev anvendt som kontrol til måling af ikke-specifik binding og prøve til prøve variabilitet. Disse perler blev behandlet identisk til antigenet koblet perler med den undtagelse, at de ikke blev inkuberet med en hvilken som helst antigen i koblingstrinnet. MFI-værdier> 500 opnået fra kontrol-perler inkuberet med alle spytprøver blev fjernet fra yderligere analyser skyldes den påståede forurening fra serum, og de resterende responser blev log fordelt. Spyt ka…

Discussion

Disse resultater indikerer, at multiplex immunoassay metode er nyttig til at skelne mellem spytprøver, der er immunpositive eller immunonegative. For at bestemme immunopositivitet, blev en enkelt skæringspunkt udviklet ved at beregne gennemsnittet plus tre standardafvigelser af de log transformeret MFI svarene fra de testede med alle de spytprøver kontrol koblede perler. Den skæringspunkt gav mulighed for at vurdere eksponeringen og immunoprevalence til enten en enkelt eller flere patogener. Denne diskriminerende ma…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

Clarissa Curioso was supported through an appointment to the Research Participation Program at the U.S. Environmental Protection Agency administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and U.S. EPA.

Materials

Equipment and Software
Microcentrifuge Thermo Electron Corporation 75002446 Used to centrifuge samples
Vortex Mixer VWR G560 Used to mix samples
Sonicator (mini) Fisher Scientific 15-337-22 Used to separate beads
Pipettors P10, P20, P100, P1000, 8 ch. Capp Various
Hemacytometer (Bright Line) Housser Scientific  3200 Used to count coupled beads
Multiscreen Vacuum Manifold Millipore MSVMHTS00 Used in washing steps to remove supernatant
MicroShaker VWR 12620-926 Used to agitate beads during incubations
Tube rack (1.5mL and 0.5mL) (assorted) VWR 30128-346
Weighing Scale Mettler or other Used to measure wash reagents for making buffers
Dynabead Sample Mixer Invitrogen 947-01 Used during coupling incubation step
MatLab (R2014b) The MathWorks, Inc. Used to analyze antibody response data
Microsoft Excel 2014 Microsoft Corporation Used to analyze antibody response data
Luminex Analyzer with xPonent 3.1 software Luminex Corporation LX200-XPON3.1 Instrument and software used to run assay
Antigens
GI.1 Norwalk Virus : p-particle Xi Jiang (CCHMC)* NA  *Cincinnati Childrens' Hospital. Final conc. 5 µg.
GII.4 Norovirus VA387 : p-particle Xi Jiang (CCHMC)* NA  *Cincinnati Childrens' Hospital. Final conc. 5 µg.
Hepatitis A Virus : grade II concentrate from cell culture Meridian Life Sciences 8505 Antigen coupled at 100 µg
Helicobacter pylori : lysate Meridian Life Sciences R14101 Antigen coupled at 25 µg
Toxoplasma gondii : recombinant p30 (SAG1) Meridian Life Sciences R18426 Antigen coupled at 25 µg
Campylobacter jejuni : heat killed whole cells KPL 50-92-93 Antigen coupled at 50 µg
Primary Antibodies
Guinea pig anti-Norovirus (CCHMC)* NA Used for coupling confirmation
Mouse anti-Hepatitis A IgG Meridian Life Sciences C65885M Used for coupling confirmation
Mouse anti-Hepatitis A IgG Meridian Life Sciences C65885M Used for coupling confirmation
BacTraceAffinity Purified Antibody to Helicobacter pylori KPL 01-93-94 Used for coupling confirmation
Goat pAb to Toxoplasma gondii Abcam Ab23507 Used for coupling confirmation
BacTrace Goat anti-Campylobacter species KPL 01-92-93 Used for coupling confirmation
Secondary  Antibodies
Biotin-SP-Conjugated AffiniPure Donkey anti-Goat IgG (H+L) Jackson 705-065-149 Used for coupling confirmation
Biotinylated Rabbit anti-Goat IgG (H+L) KPL 16-13-06 Used for coupling confirmation
Biotinylated Goat anti-Mouse IgG (H+L) KPL 16-18-06 Used for coupling confirmation
Affinity Purified Antibody Biotin Labeled Goat anti-Rabbit IgG(H+L) KPL 176-1506 Used for coupling confirmation
Affinity Purified Antibody Biotin Labeled Goat anti-Human IgG(ᵞ)  KPL 16-10-02 Used for Salivary Immunoassay
Consumables
1.5 mL copolymer microcentrifuge tubes USA Scientific 1415-2500 Used as low binding microcentrifuge tubes
10 µL pipette tip refills BioVentures 5030050C
200 µL pipette tip refills BioVentures 5030080C
1000 µL pipette tip refills BioVentures 5130140C
Aluminum foil Various Vendors Used keep beads in the dark during incubations
Deep Well plates VWR 40002-009 Used for diluting saliva samples
Multiscreen Filter Plates Millipore MABVN1250 Used to run assays
Oracol saliva collection system Malvern Medical Developments Limited Used for saliva collection
Reagents
Carboxylated microspheres (beads) Luminex Corporation Dependent on bead set Antigens are coupled to the microspheres
EDC (1-ethyl-3-[3dimethylaminopropyl] carbodiimide hydrochloride) Pierce 77149 or 22980 Used in bead activation
Sulfo-NHS (N-hydroxysulfosuccinimide) Pierce 24510 Used in bead activation
Steptavidin-R-phycoerythrin (1mg/mL) Molecular Probes S-866 Used as reporter
MES (2-[N-Morpholino]ethanesulfonic acid) Sigma M-2933 Used for coupling
Tween-20 (Polyoxyethylenesorbitan monolaurate) Sigma P-9416 Used in wash buffer to remove non-specific binding
Protein Buffers
PBS-TBN Blocking/ Storage Buffer (PBS, 0.1% BSA, 0.02% Tween-20, 0.05% Azide, pH 7.4)** Filter Sterilize and store at 4°C
PBS, pH 7.4 Sigma P-3813 138 mM NaCl, 2.7 mM KCl
BSA Sigma A-7888 0.1% (w/v)
Tween-20 Sigma P-9416 0.2% (v/v)
Sodium Azide (0.05% azide)** Sigma S-8032 **Caution: Sodium azide is acutely toxic. Avoid contact with skin and eyes. Wear appropriate PPE's. Dispose of according to applicable laws.
MES/ Coupling Buffer (0.05 M MES, pH 5.0)
MES (2-[N-Morpholino]ethanesulfonic acid) Sigma S-3139
5 N NaOH Fisher SS256-500
Assay Buffer (PBS, 1% BSA, pH 7.4)  Filter Sterilize and store at 4°C
PBS, 1% BSA, pH 7.4 Sigma P-3688 138 mM NaCl, 2.7 mM KCl, 1% BSA
Activation Buffer (0.1 M NaH2PO4, pH 6.2) Filter Sterilize and store at 4°C
NaH2PO4 (Sodium phosphate, monobasic anhydrous) Sigma S-3139 0.1M NaH2PO4
5 N NaOH Fisher SS256-500
Wash Buffer (PBS, 0.05% Tween-20, pH 7.4) Filter Sterilize and store at 4°C
PBS, 0.05% Tween-20, pH 7.4 Sigma P-3563 138 mM NaCl, 2.7 mM KCl, 0.05% TWEEN

Riferimenti

  1. Prüss-Üstün, A., Gore, F., Bartram, J. . Safer water, better health: costs, benefits and sustainability of interventions to protect and promote health. , (2008).
  2. Augustine, S., et al. Statistical approaches to developing a multiplex immunoassay for determining human exposure to environmental pathogens. J Immunol Methods. 425, 1-9 (2015).
  3. Griffin, S., et al. Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers. J Immunol Methods. 424, 53-63 (2015).
  4. Griffin, S., Chen, I., Fout, G., Wade, T., Egorov, A. Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J Immunol Methods. 364 (1-2), 83-93 (2011).
  5. Ferguson, D. Current diagnostic uses of saliva. J Dent Res. 66, 420-424 (1987).
  6. Mandel, I. The diagnostic uses of saliva. J Oral Pathol Med. 19, 119-125 (1990).
  7. Malamud, D. Saliva as a Diagnostic Fluid. Brit Med J. 305, 207-208 (1992).
  8. Ballam, L., et al. Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection. J Clin Pathol. 53, 314-317 (2000).
  9. Estevez, P., Satoguina, J., Nwakanma, D., West, S., Conway, D., Drakeley, C. Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum. Malar J. 10, 104 (2011).
  10. Abd-Alla, M., Jackson, T., Reddy, S., Ravdin, J. Diagnosis of invasive amebiasis by enzyme-linked immunosorbent assay of saliva to detect amebic lectin antigen and anti-lectin immunoglobulin G antibodies. J Clin Microbiol. 38 (6), 2344-2347 (2000).
  11. Toyoguchi, A., et al. Antibody reactivity to Cryptosporidium parvum in saliva of calves after experimental infection. J Vet Med Sci. 62 (11), 1231-1234 (2000).
  12. Choo, S., Zhang, Q., Seymour, L., Akhtar, S., Finn, A. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. J Infect Dis. 182 (4), 1260-1263 (2000).
  13. Tourinho, R., et al. Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay. J Virol Methods. 173 (2), 169-174 (2011).
  14. Moorthy, M., Daniel, H., Kurian, G., Abraham, P. An evaluation of saliva as an alternative to plasma for the detection of hepatitis C virus antibodies. Indian J Med Microbiol. 26 (4), 327-332 (2008).
  15. Moe, C., Sair, A., Lindesmith, L., Estes, M., Jaykus, L. Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen. Clin Diagn Lab Immunol. 11 (6), 1028-1034 (2004).
  16. Yap, G., Sil, B., Ng, L. Use of saliva for early dengue diagnosis. PLoS Negl Trop Dis. 5 (5), e1046 (2011).
  17. Schramm, W., Angulo, G., Torres, P., Burgess-Cassler, A. A simple saliva-based test for detecting antibodies to human immunodeficiency virus. Clin Diagn Lab Immunol. 6 (4), 577-580 (1999).
  18. Chart, H., Perry, N., Willshaw, G., Cheasty, T. Analysis of saliva for antibodies to the LPS of Escherichia coli O157 in patients with serum antibodies to E. coli O157 LPS. J Med Microbiol. 52 (Pt 7), 569-572 (2003).
  19. Ashbolt, N., Bruno, M. Application and refinement of the WHO risk framework for recreational waters in Sydney, Australia. J Water Health. 1 (3), 125-131 (2003).
  20. Westrell, T., Schonning, C., Stenstrom, T., Ashbolt, N. QMRA (quantitative microbial risk assessment) and HACCP (hazard analysis and critical control points) for management of pathogens in wastewater and sewage sludge treatment and reuse. Water Sci Technol. 50 (2), 23-30 (2004).
  21. Ashbolt, N. Microbial contamination of drinking water and disease outcomes in developing regions. Toxicology. 198 (1-3), 229-238 (2004).
  22. Eisenberg, J., Soller, J., Scott, J., Eisenberg, D., Colford, J. A dynamic model to assess microbial health risks associated with beneficial uses of biosolids. Risk Anal. 24, 221-236 (2004).
  23. Wade, T. J., et al. . Report on 2009 National Epidemiologic and Environmental Assessment of Recreational Water Epidemiology Studies, US EPA. US EPA Report Number: EPA/600/R-10/168: US EPA2011. , (2011).
  24. Fujii, Y., et al. Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models. PLoS Negl Trop Dis. 8, e3040 (2014).
  25. Rota, M., Massari, M., Gabutti, G., Guido, M., De Donno, A., Ciofi degli Atti, M. Measles serological survey in the Italian population: interpretation of results using mixture model. Vaccine. 26 (34), 4403-4409 (2008).
  26. Vyse, A., Gay, N., Hesketh, L., Pebody, R., Morgan-Capner, P., Miller, P. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect. 134 (6), 1303-1312 (2006).
  27. Baughman, A., et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol. 11 (6), 1045-1053 (2004).
  28. Clotilde, L., Bernard, C., Hartman, G., Lau, D., Carter, J. Microbead-based immunoassay for simultaneous detection of Shiga toxins and isolation of Escherichia coli O157 in foods. J Food Prot. 74 (3), 373-379 (2011).
  29. . . Luminex User Software Manual (RUO) xPONENT 3.1 Rev. 2. 3, 6-102 (2014).
  30. Waterboer, T., Sehr, P., Pawlita, M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods. 309 (1-2), 200-204 (2006).
check_url/it/54415?article_type=t

Play Video

Citazione di questo articolo
Augustine, S. A. J., Eason, T. N., Simmons, K. J., Curioso, C. L., Griffin, S. M., Ramudit, M. K. D., Plunkett, T. R. Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens. J. Vis. Exp. (115), e54415, doi:10.3791/54415 (2016).

View Video